Research & Publications
Dan Weinberger joined the faculty at Yale School of Public Health in 2013. He earned his PhD in biological sciences from Harvard School of Public Health in 2009 with a focus on microbiology and infectious disease epidemiology. He was then a postdoctoral fellow in the Division of International Epidemiology and Population Studies in the Fogarty International Center, NIH until 2012.
Research: The research in the Weinberger Lab is at the intersection of microbiology and epidemiology. We focus on understanding the biological and epidemiological drivers of respiratory infections, including pneumococcus, RSV, influenza, and Legionella. Major research areas include understanding the biological drivers of the emergence of rare pneumococcal serotypes following vaccine introduction, developing novel statistical approaches to evaluate vaccine impact from observational data, evaluating the importance of interactions among respiratory pathogens, and understanding environmental drivers of Legionellosis. We employ a variety of tools including experimental and quantitative approaches. Our work is funded by grants from the NIH/NIAID, the Bill and Melinda Gates Foundation, and the Emerging Infections Program (a collaboration between the CDC, the Connecticut Department of Public Health, and Yale). You can learn more about our research here.
Teaching: I teach the Public Health Surveillance course at YSPH. This class uses a mix of lectures, cases studies, and hands on data analysis exercises. Students learn to perform common surveillance analyses including aberration detection (e.g., CUSUM), time series analysis, and spatial cluster detection (SATSCAN). Students learn to do these analyses in either SAS or R. There are many great resources available for students learning these types of software including https://stats.idre.ucla.edu/ and https://www.datacamp.com/
Education & Training
- PhDHarvard University (2009)
- Post-doctoral fellowFogarty International Center, National Institutes of Health
- Evaluating pneumococcal vaccine impact with limited dataBanjul, Gambia (2017-2020)
- Evaluating pneumococcal vaccine impact with limited dataKisumu, Kenya (2017-2020)
- Evaluating pneumococcal vaccine impact with limited dataVientiane, Laos (2017-2020)
- Evaluating pneumococcal vaccine impact with limited dataSuva, Fiji (2017-2020)
- Pneumococcal vaccine impacts in Latin America (Pneumo VIPR)Santiago, Chile (2014-2016)
- Pneumococcal vaccine impacts in Latin America (Pneumo VIPR)Florianópolis, Brazil (2014-2016)
- Pneumococcal vaccine impacts in Latin America (Pneumo VIPR)Bogota, Colombia (2014-2016)
- Respiratory infection researchSalvador, Brazil 2013Working with local investigators to understand pathogen interactions among a favela community in Salvador, Brazil
- Studies of pneumococcal disease in adultsCopenhagen, Denmark 2009Working with local investigators to understand patterns of pneumococcal infections in adults
- Transmission of respiratory infectionsTel Aviv-Yafo, Israel 2008Collaboration to understand epidemiology of respiratory infections (pneumococcus, Staphylococcus, Haemophilus) in southern Israel and in children living in central Israel, East Jerusalem, and the West Bank.
Honors & Recognition
|Robert Austrian Award in Pneumococcal Vaccinology||International Symposium on Pneumococci and Pneumococcal Diseases||2012|